Reviewing Retractable Technologies (NYSE:RVP) & ClearPoint Neuro (NASDAQ:CLPT)

ClearPoint Neuro (NASDAQ:CLPT – Get Rating) and Retractable Technologies (NYSE:RVP – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Profitability

This table compares ClearPoint Neuro and Retractable Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-79.97%	-39.77%	-27.95%
Retractable Technologies	21.39%	32.16%	16.50%

Earnings and Valuation

This table compares ClearPoint Neuro and Retractable Technologies’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$20.55 million	9.05	-$16.43 million	($0.68)	-11.12
Retractable Technologies	$141.60 million	0.39	$56.06 million	$0.88	1.92

Retractable Technologies has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

ClearPoint Neuro has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for ClearPoint Neuro and Retractable Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	0	0	1	0	3.00
Retractable Technologies	0	0	0	0	N/A

ClearPoint Neuro currently has a consensus target price of $14.00, suggesting a potential upside of 85.19%. Given ClearPoint Neuro’s higher possible upside, research analysts plainly believe ClearPoint Neuro is more favorable than Retractable Technologies.

Insider and Institutional Ownership

15.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 9.5% of Retractable Technologies shares are held by institutional investors. 4.9% of ClearPoint Neuro shares are held by insiders. Comparatively, 49.5% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Retractable Technologies beats ClearPoint Neuro on 9 of the 13 factors compared between the two stocks.

About ClearPoint Neuro

(Get Rating)

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

About Retractable Technologies

(Get Rating)

Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.